Can an Aspirin a Day Keep Dementia at Bay?

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Target Audience

This article is intended for neurologists, family medicine/primary care practitioners, internists, neurologists, nurses, pharmacists, public health and prevention officials, and other members of the healthcare team who treat and manage elderly patients who may be at risk for cognitive decline.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly double-blind, placebo-controlled trial
  • Assess the clinical implications of the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly trial
  • Outline implications for the healthcare team

Additional Information

Partner: 
Medscape
State Relevance: 
Ohio
Pennsylvania
Illinois
District of Columbia
Maryland
Massachusetts
Course summary
Available credit: 
  • 0.25 MOC
  • 0.25 AMA PRA Category 1 Credit
  • 0.25 ANCC
Course opens: 
05/22/2020
Course expires: 
05/22/2021
Rating: 
0

News Author

Damian McNamara

Journalist, Medscape Psychiatry | Medscape Neurology

Disclosure: Damian McNamara has disclosed no relevant financial relationships.

CME Author

Laurie Barclay, MD

Freelance writer and reviewer, Medscape, LLC

Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor/CME Reviewer

Hazel Dennison, DNP, RN, FNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

CE Reviewer

Esther Nyarko, PharmD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

image

image

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

image

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For Nurses

Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number JA0007105-0000-20-077-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Available Credit

  • 0.25 MOC
  • 0.25 AMA PRA Category 1 Credit
  • 0.25 ANCC
Please login or register to take this course.

This course is offered through Medscape. To take this course you will be redirected to Medscape's website. You must have an account with Medscape in order to complete this activity. 

Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!


 

Topics

Pharmacology